Vimarsana
Biggest News Aggregation in the World

Page 2 - Midatech Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Midatech Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Midatech Pharma Today - Breaking & Trending Today

Biodexa Pharmaceuticals (LON:MTPH) Share Price Passes Above 50 Day Moving Average of $18.00 - Vimarsana News

Biodexa Pharmaceuticals (LON:MTPH) Share Price Passes Above 50 Day Moving Average of $18.00

Biodexa Pharmaceuticals Plc (LON:MTPH – Get Free Report) shares passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 18 ($0.23) and traded as high as GBX 20 ($0.25). Biodexa Pharmaceuticals shares last traded at GBX 18 ($0.23), with a volume of 73,672 shares. Biodexa […]

Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones in 2024 - Vimarsana News

Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones in 2024

Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”)Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones...

The Global Controlled Release Drug Delivery Market size is - Vimarsana News

The Global Controlled Release Drug Delivery Market size is

The coacervation provides various benefits including improved effectiveness, fewer side effects, convenience, and guaranteed linear medication...

Biodexa Pharmaceuticals (LON:MTPH) Shares Cross Above 50 Day Moving Average of $13.26 - Vimarsana News

Biodexa Pharmaceuticals (LON:MTPH) Shares Cross Above 50 Day Moving Average of $13.26

Biodexa Pharmaceuticals Plc (LON:MTPH – Free Report)’s stock price crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 13.26 ($0.17) and traded as high as GBX 20 ($0.25). Biodexa Pharmaceuticals shares last traded at GBX 18 ($0.23), with a volume of 73,672 shares trading […]

Bioasis Provides Corporate Update and Announces Suspension of Operations - Vimarsana News

Bioasis Provides Corporate Update and Announces Suspension of Operations

NEW HAVEN, Conn., June 20, 2023 -- BIOASIS TECHNOLOGIES INC. , a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factor... | June 20, 2023